Phibro Animal Health Corporation has published the transcript of its Second Quarter 2026 Earnings Call, which covered the company's financial results for the quarter ending December 31, 2025. The event was attended by key members of Phibro’s leadership team, including Chairman, President & CEO Jack Clifford Bendheim, Chief Financial Officer Glenn C. David, Executive VP of Corporate Strategy & Director Daniel M. Bendheim, and Chief Operating Officer Larry L. Miller. Analysts from leading financial institutions such as JPMorgan Chase, Morgan Stanley, BNP Paribas, and Bank of America also participated. During the call, Phibro’s management highlighted ongoing investments in research and development as well as digital capabilities, stating these are "positioning Phibro to lead the next wave of breakthroughs in Animal Health." The leadership emphasized that these initiatives are central to the company’s "Phibro Forward strategy" and are designed to build on the strength of their core business and unified leadership team. The full transcript can be accessed through the link below.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Phibro Animal Health Corporation published the original content used to generate this news brief on February 11, 2026, and is solely responsible for the information contained therein.